CLDI
Calidi Biotherapeutics Inc.
Mentions (24Hr)
550.00% Today
Reddit Posts
Mentions
Missed the ProKidney rocket after its alert. Then the CLDI alert hit last night, and I immediately put in an order for 200 shares, thinking "This is my moment!" Woke up to find my 'genius' trade is already down 14%. Oh well, it was just a $180 test!
Just one man's recommendation - set a stop loss. If it goes higher, then you're making more money. But if it pulls back, your stop loss gets triggered and you're pulled out at the designated price. ***For example:*** I bought into CLDI with 10,000 Shares back at the start of June at about $0.30 a piece. Today CLDI rocketed up to a peak of around $1.60, but seemed to be holding at $1.41 for a while. I set a Stop Loss at $1.20 in case there was a significant pullback - and there was. So while the stock collapsed back to $0.70 by the market close, I got pulled out at $1.20 automatically, ,and I'm completely okay with that outcome. Turned my initial $3,000 into $12,000. Can't be upset with that. It's a good way to guarantee a profit during volatile trading sessions, in my own experience. You can do the same with losing positions too. If you're slipping into the red and it's more than you're comfortable with, set a stop loss to pull you out if you don't want to sell outright there and then. Again with CLDI... Last week it was down to the low twenties, and I'd lost close to 1/3 of my initial investment. So I set a stop loss at $0.20 to pull me out if it dropped below that price. I considered 1/3 loss to be acceptable, but thankfully it rebounded and I made a good profit on it today.
that CLDI freefall killed an otherwise great day
RIP CLDI, my heart goes out to those that got punched.
well that was not a fun rug pull on CLDI
You missed FLT earlier this week and CLDI today
https://finance.yahoo.com/news/calidi-biotherapeutics-inc-nyse-american-123000824.html Calidi Biotherapeutics Inc. (NYSE American: **CLDI**) Developing Precision Genetic Medicine Platform for Cancer Treatment. CAR T-cell therapy is unique compared to other cancer treatments because it uses a patient’s own immune cells, which are genetically engineered to recognize and attack cancer cells with high specificity. Unlike chemotherapy or radiation, which can damage healthy cells, CAR T-cell therapy targets only cancer cells by equipping T cells with special receptors (CARs) that bind to unique proteins on tumor cells, resulting in a more personalized and potentially more effective treatment. This approach can offer hope to patients with cancers that are resistant to standard therapies.
Literally told you retards about CLDI yesterday but ok bud
Secured profit on my CLDI trade will buy back in at the end of the day Total cost: 10,000 x .25 =2,500 Total sell: 10,000 x 1.55=15,500 Total profit: 15,500 - 2,500 =13,000 Total gain: 13,000 / 2,500 =5.2 That’s a 520% gain in just a week of holding purely because I spotted this on my after hours tracker Get on my level
Resistance and support levels exist and are crucial for entries and exits. I just went 1.10 - 1.30 and then 1.10 - 1.50 on CLDI because I checked the chart and saw the resistance points at 1.26 and 1.48
$BENF with despacs like PROK, SCAG, CLDI, KIDZ, PET, ASBP exploding 200% - 500% today it's one of the lowest priced and cleanest ones out there right now with just 2.5m MC and 7m float with gap at 1.14 on daily and no approved rs BENF -- '' Investments fair value increased to $334.3 million. '' vs 2.5m MC also they just closed a primary capital transaction involving a limited partner interest in an investment fund valued at $1.91m
$BENF with despacs like PROK, SCAG, CLDI, KIDZ, PET, ASBP exploding 200% - 500% today it's one of the lowest priced and cleanest ones out there right now with just 2.5m MC and 7m float with gap at 1.14 on daily and no approved rs BENF -- '' Investments fair value increased to $334.3 million. '' vs 2.5m MC also they just closed a primary capital transaction involving a limited partner interest in an investment fund valued at $1.91m
How to find active squeezes vs. buying into a fantasy and praying for a catalyst. I’ve found that volume hits the premarket before the news in a lot of circumstances. Like I said in the above get going before the bell and find the stocks like $CLDI with crazy volume and good short metrics e.g. shares available to short going to 0 or better is when it’s bouncing off 0. You avoid pump/dumps this way. Which are easy to identify, they will have volume/price action but nothing good from a short perspective. $PLUG today is a good example of that.
For what it's worth, I'm also holding a good chunk of MRSN and OVID as well. OVID had a good day yesterday, up around 17-18%, if I remember correctly. But as far as CLDI goes right now, I have stops in place to pull me out if there's too much pullback. Already made more than 5X my initial investment. Only wish I'd bought more.
I wish it could be mandatory to list the ticker and a very short explanation why (volume, news, merger, world event). People always complain about not getting credit or downvoted and I check their comments and it's "NCNA". For someone like me, it's easy to gloss over a listed ticker, but if I see "check CLDI, insane PM volume," I'm investigating.
Loving my purchase of 10k Shares of CLDI last week right now. With this run, my account has hit a new all-time high. Just like when I made a lot on KULR back in late 2024.
Not too late to buy CLDI. Although maybe it is, trading has halted after the 300% rise today. It’s been a good day for me.
Thank you to whoever said CLDI this morning lol
CLDI halted again I have been telling you to buy biotech for months
WTF is CLDI and why didn't any of you tell me to buy it? 
Up 75% on CLDI to those who downvoted me earlier 😜
Im watching CLDI and SUGP extensively atm. Both stocks facing heavy resistance after reacting to news. If they break, they could run
CLDI 30% spike SBEV.WS 100% spike
CLDI is already running! Watch your shorts kids!
CLDI is the way today friends. Then probably GRYP tomorrow
Check a couple of my biotech gains today and ask yourself why are you feeding MM theta HUMA CLDI ICU NTLA PSTV XAIR IBIO PCSA TOVX That’s just a taste my port is full of ticking time bombs it only takes one to pull a DRUG it’s like playing the lottery with better odds that involves some kind of skill
CLDI baby! Why bother losing money to theta when you can invest in a company that could help cure cancer This is why half of my port is biotech You wish your balls we’re as big as mine
I randomly bought 100 shares of penny stock CLDI a few days ago It's now up 158% lmao, fuck me
Amazed no one is talking about $CLDI right now. Glad to have gotten in last week with 10k Shares.
Looking at the data…CREG definitely bearish outlook, it has no short interest to trap, no institutional pressure, no fresh volume. I think that CLDI is neutral to slightly bearish because it has low short interest (~1.2%) with a modest increase in recent weeks, but not enough to trigger a squeeze on its own. Volume is also drying up. But TNFA has a bullish setup watch because it has high volume today, recent reverse split (classic setup), and no clear short data yet, which could mean a trap is forming quietly. Keep an eye and DYOR….
Right now I'm pretty comfortable with what I'm holding. Feeling pretty good about it. MRSN, BDSX, and CLDI. Holding 10,000 Shares of Each. In the Green on all three.
Patiently waiting for CLDI to do something🥲
CLDI with some news https://www.stocktitan.net/news/CLDI/calidi-biotherapeutics-presents-systemic-oncolytic-platform-with-foexwmar7qqi.html
Might put my chips in CLDI to be honest…
CLDI ZNTL & LXRX. Do yourselves a favor brethren & sistren
CLDI - huge upside potential over the next year. Analysts are loving it
CLDI is making a nice little move today.
Try investing in $CLDI.
Your post with title "$CLDI has movement" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
Your post with title "Anyone got any word on $CLDI" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
Your post with title "$CLDI anyone watching this one ?" has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
I can see $CLDI reaches my $4🎯 🍌🍑💹
$CLDI is my low float play of the day 🍌🍑💹
$SOUN, $RDFN, $CLDI looking yum 🍌🍑
it’s CLDI for me
CLDI is such a buy
Sure thing: ALGS: > Aligos Therapeutics, Inc. (ALGS) is currently trading at $19, showing a strong upward momentum with the RSI indicating overbought conditions across multiple timeframes, suggesting potential for a pullback. The MACD histogram is positive, reinforcing bullish sentiment, while the stock's recent surge above its 10-day SMA of $15.81 and 20-day EMA of $13.90 highlights strong buying pressure. Despite the lack of recent news or significant market interest, the technical indicators suggest a continuation of the uptrend, albeit with caution due to overbought signals. Given the broader market's cautious optimism, ALGS may experience moderate volatility. For today's session, consider a LONG position with an entry around $18.50, targeting $21.00 as the first price target and $23.00 as the second, with a stop loss at $17.00. Confidence in reaching the first target is moderate due to current momentum, while the second target carries lower confidence given potential resistance and market uncertainties. Keep an eye on broader market movements and any emerging news that could impact sentiment. MBLY: > Mobileye Global Inc. (MBLY) is showing signs of short-term bullish momentum, supported by a positive MACD histogram and RSI levels above 60, indicating potential upward movement. The stock's current price of $16.90 is above its 10-day SMA of $16.33, suggesting recent strength, while the broader market sentiment is cautiously optimistic, with technology sectors showing resilience. Recent partnerships and speculation about growth prospects in the autonomous driving sector add to the positive sentiment, although competition remains a concern. Given the high short interest, a short squeeze could further propel the stock upwards. For today's trading session, consider a long position with an entry around $16.80, targeting $17.20 as the first price target and $17.50 as the second, with a stop loss at $16.40 to manage risk. Confidence in reaching the first target is moderate due to mixed market signals, but the second target carries lower confidence given potential resistance and broader market uncertainties. Keep an eye on upcoming announcements and market conditions for any shifts in sentiment. CLDI > Calidi Biotherapeutics, Inc. (CLDI) is currently trading at $2.40, showing a strong upward momentum following its recent public offering priced at $1.69 per share, which raised $7.5 million for operational and R&D purposes. The stock's technical indicators are bullish, with the 10-day SMA at $2.08 and the 8-day EMA at $2.18, suggesting continued upward pressure. The RSI values around 60 indicate moderate buying strength without being overbought, while the MACD histogram supports a positive trend. Despite the lack of significant market sentiment or news, the successful capital raise and potential for future growth could attract investor interest. Given the broader market's cautious optimism, CLDI may experience moderate volatility but with an upward bias. For today's session, consider a long position with an entry around $2.35, targeting $2.60 as the first price target and $2.75 as the second, with a stop loss at $2.20. Confidence in reaching the first target is moderate due to recent positive developments, while the second target carries lower confidence given potential market fluctuations. BIVI: > BioVie Inc. (BIVI) is currently trading at $3.51, showing a strong upward momentum with the 10-day SMA at $3.08 and the 8-day EMA at $3.22, indicating a bullish trend. The RSI values are high, suggesting the stock is overbought, but the MACD histogram remains positive, supporting continued upward movement. Recent trading volumes have been significant, surpassing the 65-day average, which could indicate sustained interest despite the lack of specific news catalysts. Broader market sentiment is cautiously optimistic, with SPY and QQQ showing resilience, which may support BIVI's upward trajectory. Given these factors, a long position is recommended with an entry around $3.50, targeting $3.75 as the first price target and $4.00 as the second, with a stop loss at $3.30 to manage downside risk. Confidence in reaching the first target is moderate due to current momentum, while the second target carries lower confidence given potential resistance and broader market uncertainties. Investors should remain vigilant for any sudden changes in market conditions or unexpected news that could impact BIVI's performance. NXL: > Nexalin Technology, Inc. (NXL) is currently trading at $3.97 with a market cap of approximately $49.9 million and no significant news driving its movement. The stock has shown a strong upward trend recently, with the 10-day SMA at $3.73 and the 20-day EMA at $3.12, indicating bullish momentum. The RSI values are above 60, suggesting the stock is not yet overbought but is approaching that territory. The MACD histogram is positive, reinforcing the bullish sentiment. Given the broader market's cautious optimism and NXL's technical indicators, a long position could be considered. For today's session, an entry price around $3.95 is advisable, with a first target of $4.10 and a second target of $4.25, while setting a stop loss at $3.80 to manage risk. Confidence in reaching the first target is moderate due to the lack of volume and market interest, while the second target carries lower confidence unless new catalysts emerge.
BIVI CLDI ALGS take your pick
CLDI just needs some volume. https://preview.redd.it/2fqixvjoc1dd1.jpeg?width=1080&format=pjpg&auto=webp&s=d30bab04ce180f9c25768508f22fa2d6f47e3a5b
As per the latest company webinar they discussed how the current data that has come in has allowed them high level discussions with big pharma we just had a director resign on good terms yesterday who had major connections and potential conflicts of interest at roche. this could be a sign of roche getting close to partnership. CLDI is presenting new updates on all three products at ASCO june 1. they have meetings with multiple big pharma companies at this conference. There tech is quite literally a cure for cancer they are aiming to treat all solid cancer types including lung and melanoma. There systemic therapy is getting updated with new pre clinical data at the conference as well. they own IP and licensing for all of their therapies. This is the time when the company is most likely to make a licensing deal, IMO this is most likely to happen at ASCO or the days after.
Vertiv, AppLovin, Modine, GigaCloud Technology, Xylem, Palomar Holdings, Taylor Devices, Axos Financial, Vista Energy, Southern Copper, Amphenol, CLDI, A-Mark, Astera Labs, Inc., Arista, Eastern Company, Prosus NV, Levi’s, Rolls Royce,